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Streptococcus pyogenes causes a greater diversity of human disease than any other bacterial pathogen. Here, we present the com-
plete genome sequence of the emm type 14 S. pyogenes strain HSC5. This strain is a robust producer of the cysteine protease
SpeB and is capable of producing infection in several different animal models.
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Streptococcus pyogenes is an important Gram-positive humanpathogen capable of causing a wide range of diseases, ranging
from mild superficial skin and throat infections (impetigo and
“strep throat”) to more-severe invasive diseases, including cellu-
litis and necrotizing fasciitis, as well as numerous postinfection
sequelae, including acute rheumatic fever and poststreptococcal
glomerulonephritis (1). As a strict human pathogen with no en-
vironmental or animal reservoirs, there is no single animal model
that entirely replicates the diversity of human diseases caused by
S. pyogenes. Consequently, several different animal models have
been developed thatmimic particular aspects of S. pyogenespatho-
genesis. The emm type 14 S. pyogenes strain HSC5 (2) is capable of
causing robust and highly reproducible infections in multiple an-
imal models, including a necrotizing fasciitis (myositis) model of
infection in zebrafish (Danio rerio) (3) and several distinct mouse
models, including a self-resolving subcutaneous ulcer model
(4), a lethal systemic infection following intraperitoneal injec-
tion, and a recently described asymptomatic murine mucosal
carriage model (5).
One of the most well-studied secreted virulence factors pro-
duced by S. pyogenes is the cysteine protease SpeB, which is abun-
dantly produced in many strains and is subject to multiple layers
of regulation (6). HSC5 has proven to be an exquisitely sensitive
SpeB indicator strain, as mutagenesis experiments in HSC5 have
revealed several novel SpeB regulators (7–10). Furthermore, stud-
ies on HSC5 have provided numerous insights into the funda-
mental aspects of protein secretion in S. pyogenes, including the
role of the signal recognition particle (SRP) pathway (11) and the
ExPortal protein secretion microdomain (12). We therefore
sought to determine the complete genome sequence of HSC5, the
first emm type 14 strain to be sequenced, in order to provide a
framework for future genetic studies on this versatile strain.
Genomic DNA from HSC5 was purified by phenol-
chloroform extraction (13) and sequenced using a 454 GS FLX
sequencer (MOgene LC, St. Louis, MO) by collecting shotgun
reads and 8-kb paired-end reads. A total of 202,164 reads
(64,290,146 nucleotides) were generated, reaching a depth of 35-
fold genome coverage. Sequences were assembled using Newbler
v2.5.3. A total of 26 contigs were assembled and aligned to the
S. pyogenes strain SF370 genome, generating a single scaffold that
was 96% complete. The 26 remaining gaps (ranging from0.5 kb to
16 kb, for a total of 70 kb) were filled in by primer walking (IDT,
Coralville, IA) and Sanger sequencing (GENEWIZ, South Plain-
field, NJ). To correct any sequencing errors, the genomic DNA
was resequenced by Illumina HiSeq 2000 (Genome Technology
AccessCenter [GTAC],WashingtonUniversity, St. Louis,MO)by
collecting 50-bp single-end reads, generating a total of 9,574,454
reads (403,593,696 nucleotides), reaching a depth of 222-fold ge-
nome coverage. Illumina data were aligned to the reference HSC5
scaffold sequence using DNAStar SeqManNGen 4.0.0 (DNAStar)
to generate a final consensus sequence. TheHSC5 genome is com-
posed of 1,818,351 bp, with an average GC content of 38.5%.
Nucleotide sequence accessionnumber.The completewhole-
genome sequence of S. pyogenes strainHSC5has been deposited in
the NCBI under the accession no. CP006366.
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